The National Association of People with AIDS (NAPWA) and OraSure Technologies, Inc. announced today the launch of the eighth annual Mayors Campaign Against HIV™, a national campaign to encourage testing for HIV and promote the benefits of knowing one’s HIV status. The Campaign is part of the annual observance of National HIV Testing Day (NHTD) on Wednesday, June 27, 2012.

Brazil has created and will produce a vaccine against Schistosomiasis, a chronic illness caused by the Schistosoma parasite found in areas that lack basic sanitation. On June, 12 in Rio de Janeiro, Fundação Oswaldo Cruz (Fiocruz) issued the results of clinical safety testing for the vaccine developed by the Experimental Schistosomiasis Laboratory of Instituto Oswaldo Cruz (IOC/Fiocruz). Based on the antigen Sm14, developed and patented by the IOC, the vaccine puts Brazil at the forefront of knowledge in a field of high technological complexity.

Noting that the "[r]oll-out of antiretroviral treatment for HIV in sub-Saharan Africa has been accompanied by rising rates of drug resistance," Raph Hamers, a global health research fellow at the Academic Medical Centre of the University of Amsterdam, and colleagues "call for improved patient management and the integration of population-based drug resistance surveillance into national treatment programs" in this BMJ analysis.

Online Collection Illustrates Efforts of Productive Partnerships

May 18, 2012 – Chicago, IL – Successful multi-sector global health programs engage partners and policymakers early, communicate openly and frequently with relevant stakeholders, and empower and involve communities, according to a website relaunched this week, Case Studies for Global Health,

Radio Australia
May 24, 2012

A new American study has found that fake malaria drugs are threatening the gains made in the fight against the deadly disease.

Researchers at the US National Institute of Health have found that more than one third of the anti-malarial drugs in Southeast Asia are fake and that a third of samples in sub-Saharan Africa don't contain the right ingredients.

The World Health Assembly today appointed Dr Margaret Chan for a second five-year term as Director-General of the World Health Organization (WHO). In her acceptance speech to health ministers and representatives of WHO’s Member States, Dr Chan pledged her continued commitment to improve the health of the most vulnerable. In addition she said that the biggest challenge over the next five years will be to lead WHO in ways that will help maintain the unprecedented momentum for better health that marked the start of this century.

The Bristol-Myers Squibb Foundation has announced a $15 million commitment to bring its Together on Diabetes initiative to China and India. According to the International Diabetes Foundation, more than 9 percent of the population in China and 8.3 percent of the Indian population suffers from type 2 diabetes, and IDF projects those numbers will rise significantly by 2030.

The U.S. President's Emergency Plan for AIDS Relief, the government's far-reaching health-care foreign aid program, has contributed to a significant decline in adult death rates from all causes in Africa, according to a new study by Stanford University School of Medicine researchers.

BRASÍLIA, Brazil – The Brazilian Ministry of Health today announced a strategic alliance with the Bill & Melinda Gates Foundation to prioritize the development of solutions for pressing global health issues. This Alliance will dedicate resources to explore new ways of tackling challenges associated with vaccines, nutrition, maternal and child health, and infectious disease control.

Haiti, the United States and international partners are launching a nationwide vaccination campaign in the Caribbean country that seeks to curb or prevent infectious diseases. The campaign will be supported in part by the GAVI Alliance, a group of international health organizations, the Bill & Melinda Gates Foundation and others, and the U.S. Centers for Disease Control and Prevention in Atlanta. In 2012, the GAVI Alliance will provide Haiti with $2.15 million for the pentavalent vaccine in Haiti. The Haitian government will contribute $177,500, which is being paid for by the CDC. GAVI also provided $100,000 to the Haitian government to train health workers.